The American Society of Health-System Pharmacists (ASHP) had representatives at a White House meeting regarding opioid abuse this week. Read More »

The U.S. Food and Drug Administration (FDA) announced that it has approved a buprenorphine implant for the treatment of opioid dependence this week. Read More »

CVS Health announced the launch of a digital tool that will allow patients to view wait times at MinuteClinic locations, which is expected to include CVS locations in Target stores later in 2016. Read More »

The Daiichi Sankyo Co. announced this week that it will be joining Takeda Pharmaceutical Limited and Astellas Pharma Inc. in researching the development of a biomarker database. Read More »

The Food and Drug Administration (FDA) has accepted a new drug application (NDA) from Allergan for a cream to treat symptoms of rosacea in adults, the company announced this week. Read More »

Walgreens Boots Alliance Inc. (WBA) announced this week that Barry Rosenstein has stepped down from the company’s board of directors. Read More »

CVS Health announced this week that it will be expanding access to naloxone, a drug used to reverse an opioid overdose, to seven additional states this summer. Read More »

AstraZeneca completed the acquisition of Takeda's core respiratory business recently. Read More »

NRLS allows health clinicians to locate patient records no matter where they were previously treated. Read More »

Outlines steps to reduce opioid use and treat substance abuse as a chronic disease. Read More »

New safety and efficiency data included on labels after EAGLES clinical trial. Read More »

ExtraCare Rewards members can select digital receipts for in-store purchases. Read More »

IBS-DonTract.com provides information and support to patients with IBS-D. Read More »

NACDS evaluating how increased access to Hepatitis C and HIV testing increases patient screenings. Read More »

Phase III study in Japan shows positive results in participants with advanced lung cancer. Read More »

More than 40 states have joined NABP PMP InterConnect to reduce prescription drug abuse. Read More »

Online program supports cystic fibrosis patients, caregivers and others affected by the disease. Read More »

Cigna Corp. may receive additional price discounts from pharmaceutical companies should new cholesterol medications prove less effective than expected — a move marks a crucial step in a broader initiative to link the cost of medications to their efficacy. Read More »

A new law in Indiana gives pharmacists the freedom of judgment to determine whether to dispense decongestants in an effort to interrupt the supply chain that produces methamphetamines Read More »

Maine Gov. Paul R. LePage recently signed into law a new state law that limits the doses, duration, and overall prescription of opioid therapies. Read More »